Sun Pharma.Inds.

{
  "main_header": {
    "sid": 948699,
    "name": "Sun Pharma.Inds.",
    "stock_name": "Sun Pharma.Inds.",
    "full_name": "Sun Pharmaceutical Industries Ltd",
    "name_url": "stocks-analysis/sun-pharmainds",
    "exchange": 1,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,861.90",
    "chg": -10.8,
    "chgp": "-0.58%",
    "dir": -1,
    "prev_price": "1,872.70",
    "mcapval": "446,732.18 Cr",
    "mcap": "Large Cap",
    "scripcode": 524715,
    "symbol": "SUNPHARMA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE044A01036",
    "curr_date": "May 12",
    "curr_time": "",
    "bse_nse_vol": "16.63 lacs",
    "exc_status": "Active",
    "traded_date": "May 12, 2026",
    "traded_date_str": "2026 05 12",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/sun-pharmainds-948699-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Sun Pharmaceutical Industries Sees Significant Open Interest Surge Amidst Strong Market Positioning",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-industries-sees-significant-open-interest-surge-amidst-strong-market-positioning-3987543",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/SunPharmaceutic_oi_spurts_by_underlying_3987543.png",
        "date": "2026-05-12 11:00:13",
        "description": "Sun Pharmaceutical Industries Ltd has witnessed a notable surge in open interest in its derivatives segment, signalling a shift in market positioning and potential directional bets by investors. The increase of over 10% in open interest, coupled with steady volume and price action near its 52-week high, suggests growing investor conviction in the pharmaceutical giant’s near-term prospects."
      },
      {
        "title": "Rs 1900 Calls on Sun Pharmaceutical Industries Ltd See Heavy Activity — What the Strike Price Tells You",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-sees-surge-in-call-option-activity-ahead-of-may-expiry-3987190",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/SunPharmaceutic_most_active_stocks_calls_3987190.png",
        "date": "2026-05-12 10:00:14",
        "description": "4,070 call contracts at the Rs 1,900 strike traded on 12 May 2026 for Sun Pharmaceutical Industries Ltd, with the stock closing just below at Rs 1,873.80. This near-the-money activity coincides with the stock trading close to its 52-week high, signalling a focused directional bet in the options market that aligns closely with the underlying price action."
      },
      {
        "title": "P/E at 37.0 vs Industry's 34.43: What the Data Shows for Sun Pharmaceutical Industries Ltd",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-industries-ltd-strong-buy-momentum-amid-nifty-50-membership-and-institutional-confidence-3987010",
        "imagepath": "",
        "date": "2026-05-12 09:21:06",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <p><strong>Significance of Nifty 50 Membership</strong></p>\n                <p>As a prominent member of the Nifty 50 index, Sun Pharmaceutical Industries Ltd holds a strategic position within India’s benchmark equity gauge. Inclusion in this elite group not only enhances the stock’s visibility among domestic and global investors but also ensures consistent demand from index-tracking funds and institutional portfolios. This membership acts as a catalyst for liquidity and price stability, particularly during periods of market volatility.</p>\n                <p>The company’s large-cap status, with a market capitalisation of ₹4,49,251 crores, further cements its role as a cornerstone of the Pharmaceuticals & Biotechnology sector. Its weighting within the Nifty 50 reflects both its market val..."
      },
      {
        "title": "10,985 Call Contracts Traded on Sun Pharmaceutical Industries Ltd as Stock Rallies 2.3% in Two-Day Streak",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-sees-surge-in-call-option-activity-amid-bullish-momentum-3985628",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/SunPharmaceutic_most_active_stocks_calls_3985628.png",
        "date": "2026-05-11 12:00:05",
        "description": "10,985 call contracts on Sun Pharmaceutical Industries Ltd changed hands on 11 May 2026, coinciding with a 2.31% gain over two consecutive sessions. The stock closed near Rs 1,876, just below the Rs 1,900 strike price, signalling a strong alignment between the options market and the underlying cash price."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Sun Pharmaceutical Industries Ltd to 52-Week High of Rs 1875.55",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-industries-ltd-hits-new-52-week-high-at-rs187555-3985543",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/SunPharmaceutic_priceRelatedfactors_3985543.png",
        "date": "2026-05-11 10:37:02",
        "description": ""
      },
      {
        "title": "P/E at 36.36 vs Industry's 34.29: What the Data Shows for Sun Pharmaceutical Industries Ltd",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-industries-ltd-strengthens-position-as-a-nifty-50-constituent-amid-robust-institutional-support-3984993",
        "imagepath": "",
        "date": "2026-05-11 09:21:03",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <p><strong>Valuation Picture: Premium Amidst Sector Norms</strong></p>\n                <p>The current P/E ratio of 36.36 for <a href=\"https://www.marketsmojo.com/stocks-analysis/sun-pharma.inds.-948699-0\" class=\"stk\">Sun Pharmaceutical Industries Ltd</a> is marginally higher than the sector average of 34.29. This premium suggests that investors are willing to pay slightly more for the stock relative to its peers, possibly reflecting expectations of superior earnings growth or stability. However, the premium is not excessive, indicating that valuation remains within a reasonable range compared to the broader Pharmaceuticals &amp; Biotechnology industry. The sector itself has shown a predominantly positive earnings trend, with 7 out of 9 stocks reporting positive results recently, one flat..."
      },
      {
        "title": "Sun Pharmaceutical Industries Ltd Gains 1.27%: 3 Key Factors Driving the Week",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-industries-ltd-gains-127-3-key-factors-driving-the-week-3983262",
        "imagepath": "",
        "date": "2026-05-09 14:04:58",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>4 May:</strong> Week opens at Rs.1,824.10</p>\n                    <p><strong>6 May:</strong> New 52-week high near Rs.1,843.95 and upgrade to Strong Buy</p>\n                    <p><strong>7 May:</strong> Minor pullback to Rs.1,834.40 amid mixed market signals</p>\n                    <p><strong>8 May:</strong> Week closes at Rs.1,847.30, up 1.27% for the week</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\">\n                        <div class=\"stat-label\">Week Open</div>\n                        <div class=\"stat-value\">Rs.1,824.10</div>\n                    </div>\n                    <div class=\"stat-item\">\n               ..."
      },
      {
        "title": "P/E at 36.19 vs Industry's 34.54: What the Data Shows for Sun Pharmaceutical Industries Ltd",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-industries-ltd-strong-buy-rating-reinforces-its-nifty-50-significance-3981028",
        "imagepath": "",
        "date": "2026-05-08 09:21:22",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <p><strong>Index Membership and Market Capitalisation Impact</strong></p>\n                <p>As a prominent member of the Nifty 50, Sun Pharmaceutical Industries Ltd holds considerable influence on the index’s overall performance. With a market capitalisation of ₹4,40,038.03 crores, it ranks among the largest companies in the Pharmaceuticals & Biotechnology sector, a segment that has demonstrated resilience amid volatile market conditions. The company’s inclusion in the Nifty 50 not only reflects its scale and liquidity but also ensures significant institutional participation, as many mutual funds and ETFs track this benchmark closely.</p>\n                <p>The stock’s current valuation metrics reveal a price-to-earnings (P/E) ratio of 36.19, slightly above the industry average of 34.54..."
      },
      {
        "title": "P/E at 36.57 vs Industry's 34.48: What the Data Shows for Sun Pharmaceutical Industries Ltd",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-industries-ltd-strong-buy-momentum-amidst-nifty-50-benchmark-significance-3979161",
        "imagepath": "",
        "date": "2026-05-07 09:21:09",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <p><strong>Valuation Picture: Premium Amidst Sector Norms</strong></p>\n                <p><a href=\"https://www.marketsmojo.com/stocks-analysis/sun-pharma.inds.-948699-0\" class=\"stk\">Sun Pharmaceutical Industries Ltd</a> trades at a P/E of 36.57, slightly above the Pharmaceuticals & Biotechnology industry average of 34.48. This premium, approximately 6.0%, suggests that investors are willing to pay more for the stock relative to its peers, reflecting expectations of either superior earnings growth or a perception of higher quality. However, this valuation is not excessively stretched compared to some high-growth peers in the sector. The market capitalisation of Rs 4,43,973 crore firmly places the company in the large-cap category, underscoring its established presence in the industry.</p>..."
      }
    ],
    "total": 1100,
    "sid": "948699",
    "stock_news_url": "https://www.marketsmojo.com/news/sun-pharmaceutical-industries-948699"
  },
  "announcements": [
    {
      "details": "Sun Pharmaceutical Industries Limited has informed the Exchange regarding Intimation under Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015",
      "source": "NSE",
      "caption": "Sun Pharmaceutical Industries Limited - Other General Purpose",
      "datetime": "09-Dec-2019"
    },
    {
      "details": "Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated November 06, 2019, titled \"Sun Pharma and AstraZeneca enter into License Agreement for Novel Oncology products in China\".",
      "source": "NSE",
      "caption": "Sun Pharmaceutical Industries Limited - Press Release",
      "datetime": "06-Nov-2019"
    },
    {
      "details": "Sun Pharmaceutical Industries Limited has informed the Exchange regarding 'Please find enclosed Compliance Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018'.",
      "source": "NSE",
      "caption": "Sun Pharmaceutical Industries Limited - Updates",
      "datetime": "18-Oct-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Sun Pharmaceutical Industries Ltd has declared <strong>1100%</strong> dividend, ex-date: 05 Feb 26",
          "dt": "2026-02-05",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Sun Pharmaceutical Industries Ltd has announced <strong>1:5</strong> stock split, ex-date: 25 Nov 10",
          "dt": "2010-11-25",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Sun Pharmaceutical Industries Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 29 Jul 13",
          "dt": "2013-07-29",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Sun Pharmaceutical Industries Sees Significant Open Interest Surge Amidst Strong Market Positioning

2026-05-12 11:00:13

Sun Pharmaceutical Industries Ltd has witnessed a notable surge in open interest in its derivatives segment, signalling a shift in market positioning and potential directional bets by investors. The increase of over 10% in open interest, coupled with steady volume and price action near its 52-week high, suggests growing investor conviction in the pharmaceutical giant’s near-term prospects.

Read full news article

Rs 1900 Calls on Sun Pharmaceutical Industries Ltd See Heavy Activity — What the Strike Price Tells You

2026-05-12 10:00:14

4,070 call contracts at the Rs 1,900 strike traded on 12 May 2026 for Sun Pharmaceutical Industries Ltd, with the stock closing just below at Rs 1,873.80. This near-the-money activity coincides with the stock trading close to its 52-week high, signalling a focused directional bet in the options market that aligns closely with the underlying price action.

Read full news article

P/E at 37.0 vs Industry's 34.43: What the Data Shows for Sun Pharmaceutical Industries Ltd

2026-05-12 09:21:06

Significance of Nifty 50 Membership

As a prominent member of the Nifty 50 index, Sun Pharmaceutical Industries Ltd holds a strategic position within India’s benchmark equity gauge. Inclusion in this elite group not only enhances the stock’s visibility among domestic and global investors but also ensures consistent demand from index-tracking funds and institutional portfolios. This membership acts as a catalyst for liquidity and price stability, particularly during periods of market volatility.

The company’s large-cap status, with a market capitalisation of ₹4,49,251 crores, further cements its role as a cornerstone of the Pharmaceuticals & Biotechnology sector. Its weighting within the Nifty 50 reflects both its market val...

Read full news article

10,985 Call Contracts Traded on Sun Pharmaceutical Industries Ltd as Stock Rallies 2.3% in Two-Day Streak

2026-05-11 12:00:05

10,985 call contracts on Sun Pharmaceutical Industries Ltd changed hands on 11 May 2026, coinciding with a 2.31% gain over two consecutive sessions. The stock closed near Rs 1,876, just below the Rs 1,900 strike price, signalling a strong alignment between the options market and the underlying cash price.

Read full news article

Broad-Based Technical Strength Lifts Sun Pharmaceutical Industries Ltd to 52-Week High of Rs 1875.55

2026-05-11 10:37:02

Read full news article

P/E at 36.36 vs Industry's 34.29: What the Data Shows for Sun Pharmaceutical Industries Ltd

2026-05-11 09:21:03

Valuation Picture: Premium Amidst Sector Norms

The current P/E ratio of 36.36 for Sun Pharmaceutical Industries Ltd is marginally higher than the sector average of 34.29. This premium suggests that investors are willing to pay slightly more for the stock relative to its peers, possibly reflecting expectations of superior earnings growth or stability. However, the premium is not excessive, indicating that valuation remains within a reasonable range compared to the broader Pharmaceuticals & Biotechnology industry. The sector itself has shown a predominantly positive earnings trend, with 7 out of 9 stocks reporting positive results recently, one flat...

Read full news article

Sun Pharmaceutical Industries Ltd Gains 1.27%: 3 Key Factors Driving the Week

2026-05-09 14:04:58

Key Events This Week

4 May: Week opens at Rs.1,824.10

6 May: New 52-week high near Rs.1,843.95 and upgrade to Strong Buy

7 May: Minor pullback to Rs.1,834.40 amid mixed market signals

8 May: Week closes at Rs.1,847.30, up 1.27% for the week

Week Open

Rs.1,824.10

...

Read full news article

P/E at 36.19 vs Industry's 34.54: What the Data Shows for Sun Pharmaceutical Industries Ltd

2026-05-08 09:21:22

Index Membership and Market Capitalisation Impact

As a prominent member of the Nifty 50, Sun Pharmaceutical Industries Ltd holds considerable influence on the index’s overall performance. With a market capitalisation of ₹4,40,038.03 crores, it ranks among the largest companies in the Pharmaceuticals & Biotechnology sector, a segment that has demonstrated resilience amid volatile market conditions. The company’s inclusion in the Nifty 50 not only reflects its scale and liquidity but also ensures significant institutional participation, as many mutual funds and ETFs track this benchmark closely.

The stock’s current valuation metrics reveal a price-to-earnings (P/E) ratio of 36.19, slightly above the industry average of 34.54...

Read full news article

P/E at 36.57 vs Industry's 34.48: What the Data Shows for Sun Pharmaceutical Industries Ltd

2026-05-07 09:21:09

Valuation Picture: Premium Amidst Sector Norms

Sun Pharmaceutical Industries Ltd trades at a P/E of 36.57, slightly above the Pharmaceuticals & Biotechnology industry average of 34.48. This premium, approximately 6.0%, suggests that investors are willing to pay more for the stock relative to its peers, reflecting expectations of either superior earnings growth or a perception of higher quality. However, this valuation is not excessively stretched compared to some high-growth peers in the sector. The market capitalisation of Rs 4,43,973 crore firmly places the company in the large-cap category, underscoring its established presence in the industry.

...

Read full news article

View All News